A preparation of Coptis chinensis for treating damp-heat and qi stagnation in the gastrointestinal tract and its preparation method
By constructing a nano-targeted delivery system and a thermosensitive gel matrix formulation, the problems of low extraction efficiency of active ingredients and non-targeted drug release in traditional Xianglian formulations have been solved, achieving precise targeted drug release and efficient therapeutic effects, and improving the stability and safety of the formulation.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- HUBEI XIANGLIAN PHARMA
- Filing Date
- 2026-04-22
- Publication Date
- 2026-06-02
AI Technical Summary
Traditional Xianglian preparations have many problems in terms of active ingredient extraction, drug delivery and formulation production, including loss due to oxidation and decomposition of heat-sensitive components, low extraction efficiency of active ingredients, lack of targeted delivery system, non-selective release of drugs in the gastrointestinal tract, and unstable formulation quality, making it difficult to meet the needs of personalized medication.
A thermosensitive gel matrix formulation was constructed by combining a nano-targeted delivery system with targeted peptide modification of colonic epithelial cells. The precise extraction and targeted release of the drug were achieved by supercritical CO2 extraction and dynamic cyclic extraction combined with near-infrared online monitoring technology. The thermosensitive gel matrix formulation was prepared using 3D printing technology.
It achieves efficient retention and precise targeted release of active pharmaceutical ingredients, increases local drug concentration, reduces systemic side effects, ensures formulation quality stability, and meets personalized medication needs.
Smart Images

Figure CN122124179A_ABST